Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Cullin 4B is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.

Jiang T, Tang HM, Wu ZH, Chen J, Lu S, Zhou CZ, Yan DW, Peng ZH.

Med Oncol. 2013;30(2):534. doi: 10.1007/s12032-013-0534-7. Epub 2013 May 7.

PMID:
23649548
2.

Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.

Zhou E, Huang Q, Wang J, Fang C, Yang L, Zhu M, Chen J, Chen L, Dong M.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8018-27. eCollection 2015.

3.

Ubiquitin-like with PHD and ring finger domains 2 is a predictor of survival and a potential therapeutic target in colon cancer.

Lu S, Yan D, Wu Z, Jiang T, Chen J, Yuan L, Lin J, Peng Z, Tang H.

Oncol Rep. 2014 Apr;31(4):1802-10. doi: 10.3892/or.2014.3035. Epub 2014 Feb 19.

PMID:
24573556
4.

Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.

Zhang Y, Zhang M, Yu F, Lu S, Sun H, Tang H, Peng Z.

J Exp Clin Cancer Res. 2015 Dec 1;34:145. doi: 10.1186/s13046-015-0261-3.

5.

Overexpression of eIF3e is correlated with colon tumor development and poor prognosis.

Li Z, Lin S, Jiang T, Wang J, Lu H, Tang H, Teng M, Fan J.

Int J Clin Exp Pathol. 2014 Sep 15;7(10):6462-74. eCollection 2014.

6.

IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.

Li D, Yan D, Tang H, Zhou C, Fan J, Li S, Wang X, Xia J, Huang F, Qiu G, Peng Z.

Ann Surg Oncol. 2009 Dec;16(12):3499-506. doi: 10.1245/s10434-009-0648-5.

PMID:
19672661
7.

Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery.

Yan DW, Li DW, Yang YX, Xia J, Wang XL, Zhou CZ, Fan JW, Wen YG, Sun HC, Wang Q, Qiu GQ, Tang HM, Peng ZH.

Br J Cancer. 2010 Sep 28;103(7):961-9. doi: 10.1038/sj.bjc.6605870. Epub 2010 Aug 31.

8.

Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer.

Jia L, Yan F, Cao W, Chen Z, Zheng H, Li H, Pan Y, Narula N, Ren X, Li H, Zhou P.

J Biol Chem. 2017 Feb 17;292(7):2966-2978. doi: 10.1074/jbc.M116.765230. Epub 2016 Dec 14.

PMID:
27974468
9.

Period 1 and estrogen receptor-beta are downregulated in Chinese colon cancers.

Wang Y, Xing T, Huang L, Song G, Sun X, Zhong L, Fan J, Yan D, Zhou C, Cui F, Yu F, Chen J, Yu Y, Li C, Tang H, Peng Z, Wang X.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8178-88. eCollection 2015.

10.

Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.

Yang SS, Gao Y, Wang DY, Xia BR, Liu YD, Qin Y, Ning XM, Li GY, Hao LX, Xiao M, Zhang YY.

Histopathology. 2016 Aug;69(2):276-87. doi: 10.1111/his.12933. Epub 2016 Mar 17.

PMID:
26799253
11.

Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.

Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD.

World J Gastroenterol. 2015 Jun 7;21(21):6649-59. doi: 10.3748/wjg.v21.i21.6649.

12.

Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.

Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T.

J Clin Pathol. 2015 Oct;68(10):795-801. doi: 10.1136/jclinpath-2015-202987. Epub 2015 Jun 4.

PMID:
26043748
13.

Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.

Li D, Peng X, Yan D, Tang H, Huang F, Yang Y, Peng Z.

Ann Surg Oncol. 2011 Jul;18(7):2074-83. doi: 10.1245/s10434-011-1567-9. Epub 2011 Mar 26.

PMID:
21442350
14.

Cullin 4B protein ubiquitin ligase targets peroxiredoxin III for degradation.

Li X, Lu D, He F, Zhou H, Liu Q, Wang Y, Shao C, Gong Y.

J Biol Chem. 2011 Sep 16;286(37):32344-54. doi: 10.1074/jbc.M111.249003. Epub 2011 Jul 27.

15.

Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.

Li DD, Fu ZQ, Lin Q, Zhou Y, Zhou QB, Li ZH, Tan LP, Chen RF, Liu YM.

World J Gastroenterol. 2015 Aug 21;21(31):9348-57. doi: 10.3748/wjg.v21.i31.9348.

16.

Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.

Xiao M, Xu Q, Lou C, Qin Y, Ning X, Liu T, Zhao X, Jia S, Huang Y.

Hum Pathol. 2017 Apr;62:40-49. doi: 10.1016/j.humpath.2016.12.020. Epub 2017 Jan 10.

PMID:
28087477
17.

Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.

Guo J, Dong B, Ji JF, Wu AW.

World J Gastroenterol. 2012 Oct 14;18(38):5434-41. doi: 10.3748/wjg.v18.i38.5434.

18.

E3 ubiquitin ligase Cullin4B mediated polyubiquitination of p53 for its degradation.

Thirunavukarasou A, Singh P, Govindarajalu G, Bandi V, Baluchamy S.

Mol Cell Biochem. 2014 May;390(1-2):93-100. doi: 10.1007/s11010-014-1960-3. Epub 2014 Jan 23.

PMID:
24452595
19.

Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.

He C, Bian XY, Ni XZ, Shen DP, Shen YY, Liu H, Shen ZY, Liu Q.

World J Gastroenterol. 2013;19(14):2171-8. doi: 10.3748/wjg.v19.i14.2171.

20.

Supplemental Content

Support Center